Search
Facebook Twitter RSS
 
 

 

Print

 

 

 

2002 Archives (listed in reverse chronological order)

Please click HERE to return to the archives main menu. You may also use the search tool located in the navigation bar.

Date Posted Subject
Dec. 17, 2002 FDA/CBER: Licensed/Approved HIV, HTLV and Hepatitis Tests
Dec. 16, 2002 "Can You Use the Internet to Teach SBB Students? An Old Dog Learns New Tricks!" An innovative distance education program from UTMB (Galveston) Powerpoint presentation
Dec. 6, 2002 AABB Association Bulletin #02-07: Update on Blood Donor and Hemochromatosis: Questions and Answers (Supercedes #00-2) (AABB membership required to access)
Nov. 27, 2002 CAP reports on Laboratory Information Systems - November 2002 (PDF)
Nov. 15, 2002 FDA-CDRH Medical Device Reporting Guidance - Needlesticks and Blood Exposure  
Nov. 12, 2002 CDC is recommending the use of alcohol-based handrubs by health care personnel for patient care; Fact Sheet on Guidelines on Hand Hygeine; Fact Sheet on HICPAC
Oct. 29, 2002 CAP Survey of Blood Bank Information Systems (PDF) (CAP Today - Oct. 2002)
Oct. 24, 2002 Comparison of CPDA vs. AS red cell transfusion to infants on ECMO  (Poster presentation, ASCP/CAP Annual Meeting 2002) (PDF) (see discussion in e-Network Forum, Nov. 7)
Oct. 23, 2002 FDA undecided about use of tiny implantable ID chip for medical purposes (Wired)
Oct. 18, 2002 CAP Today: Order in the blood bank: automation steps up
Oct. 3, 2002 The Role Of Various Considerations In Decision-Making Related To New And Existing Blood Safety Measures (Transcript, Aug. 2002 meeting of HHS Advisory Committee on Blood Safety & Availability)
Oct. 3, 2002 What lessons can be learned from the events of September 11, 2001 that would strengthen the safety and availability of the US blood supply? (Transcript, Feb. 2002 meeting of HHS Advisory Committee on Blood Safety & Availability)
Sept. 26, 2002 CAP Q-Probes quality improvement programs proven useful as measurement and benchmarking tools for laboratories, including those laboratories that support transfusion services. The CAP Q-Probe and Q-Tracks studies have shown that quality is not static, but rather is a moving benchmark of performance.
Sept. 25, 2002 CAP Today: New Q-Probe looks at types and screens for scheduled surgeries

SEE RELATED ISSUES IN FORUM ARCHIVES:
Aug. 31, 2002 FDA Approves Rhode Island Blood Center's Request to Accept Donors Who Have had Tattoos from Licensed Establishments within the Last Year
Aug. 27, 2002 Transfusion medicine leaders urge blood collection community to immediately initiate program to detect bacteria in platelet products (PDF file)
July 30, 2002 The Wrong Patient - a very telling example of the kind of situation that leads up to a fatal transfusion reaction
July 29, 2002 CAP Study shows Continuous Wristband Monitoring Over 2 Years Decreases Identification Errors
July 17, 2002 FDA Completes Safety Assessment of PVC Devices Containing the Plasticizer DEHP
July 24, 2002 AABB Association Bulletin # 02-4: Update on Provision of CMV-Reduced-Risk Cellular Blood Components (#97-2) (AABB membership required to access)
July 7, 2002 CT ratios, plus RBC, FFP and platelet expiration and wastage rates
June 25, 2002 Testing Autologous Blood Units - Q and A (AABB)
June 24, 2002 Highlights of the AABB Oxygen Therapeutics Conference, May 30-31 2002 (3 parts)
June 20, 2002 "Red Gold - The Epic Story of Blood" - a 4-part PBS-TV series on blood - Sun. June 23 & 30 (funded by Chiron & Ortho CD)
June 16, 2002 CAP launches new service for reminding people to donate blood (Sign-up page)
May 17, 2002 New FDA Compliance Policy Guide - CPG Sec. 230.150 Blood Donor Classification Statement, Paid or Volunteer Donor (05/07/2002 new)
April 4, 2002 Deferral from blood donation of individuals who received human growth hormone
Mar. 25, 2002 Chagas Disease After Organ Transplantation (see discussion in e-network Forum, Mar. 29)
Mar. 17, 2002 Nurses, Pathologists and the Laboratory Collaborate on Blood Safety Project
Jan. 10, 2002 Revised FDA Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products (FDA/CBER)

 

Back to Top

 
Login Join